rc 3095 has been researched along with Cancer of Colon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Groot, K; Halmos, G; Miller, G; Milovanovic, S; Radulovic, S; Reile, H; Schally, AV; Szepeshazi, K; Yano, T | 1 |
| Miller, G; Radulovic, S; Schally, AV | 1 |
2 other study(ies) available for rc 3095 and Cancer of Colon
| Article | Year |
|---|---|
Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bombesin; Colonic Neoplasms; Drug Screening Assays, Antitumor; ErbB Receptors; Gastrin-Releasing Peptide; Gastrins; Growth Hormone; Humans; Insulin-Like Growth Factor I; Liver Neoplasms; Male; Mice; Mice, Nude; Neoplasm Transplantation; Peptide Fragments; Peptides; Radioligand Assay; Somatostatin | 1994 |
Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095).
Topics: Animals; Antineoplastic Agents; Bombesin; Cell Division; Cell Line; Colonic Neoplasms; Gastrins; Growth Hormone; Humans; Insulin-Like Growth Factor I; Kinetics; Mice; Mice, Nude; Neoplasm Transplantation; Peptide Fragments; Somatostatin; Transplantation, Heterologous | 1991 |